Offstream
news

Sri Lanka receives a shipment of 300,000 doses of the Sinopharm BBIBP-CorV vaccine donated from China's People's Liberation Army.
2021-08-28

The National Agency for Food and Drug Administration and Control approves the Sinopharm BBIBP-CorV vaccine for emergency use in Nigeria.
2021-08-24

Kenya's Pharmacy and Poisons Board grants emergency use authorization for the Moderna and Sinopharm BBIBP-CorV vaccines.
2021-08-19

Cambodia begins to administer the Oxford–AstraZeneca COVID-19 vaccine as a third "booster" dose to people who have received the inactivated virus vaccines developed by Sinopharm (BBIBP-CorV) and Sinovac (CoronaVac) in order to strengthen immunity against the SARS-CoV-2 Delta variant.
2021-08-12

Egypt receives its first shipment of raw materials used to manufacture the Sinovac Coronavac vaccine, as well as a shipment of 500,000 doses of the Sinopharm vaccine.
2021-05-21

Egypt signs an agreement to purchase 20 million doses of the Sinopharm BBIBP-CorV vaccine and expects a delivery of 500,000 doses this month.
2021-04-20

Georgia receives 100,000 doses of the Sinopharm BBIBP-CorV vaccine. However, vaccination will not begin until the country receives an approval from the World Health Organization.
2021-04-3

Prime Minister Viktor Orbán receives the first dose of the Sinopharm BBIBP-CorV vaccine.
2021-02-28

Argentina receives the first shipment of 904,000 doses of Sinopharm's BBIBP-CorV vaccine.
2021-02-25

China approves BBIBP-CorV made by Sinopharm for general use, after the vaccine was considered to be 79.34% effective.
2020-12-31